EP3972604
Brútons-týrósín-kínasa-hindri til notkunar við meðhöndlun á langvinnri sjálfkrafa þinu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
20.5.2020EP published:
4.6.2025EP application number:
20729204.6
EP translation filed:
27.8.2025Grant published:
15.9.2025EPO information:
European Patent Register
Max expiry date:
19.5.2040Expiry date:
19.5.2026
Title in English:
A BRUTON'S TYROSINE KINASE INHIBITOR FOR USE IN THE TREATMENT OF CHRONIC SPONTANEOUS URTICARIALanguage of the patent:
English
Timeline
Today
20.5.2020EP application
4.6.2025EP Publication
27.8.2025Translation submitted
15.9.2025Registration published
19.5.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
BHATTACHARYA, SouvikAddress:
Cambridge, Massachusetts 02139, US
Name:
BIETH, BrunoAddress:
4002 Basel, CH
Name:
CABANSKI, MaciejAddress:
4002 Basel, CH
Name:
CENNI, BrunoAddress:
4002 Basel, CH
Name:
DE BUCK, StefanAddress:
4002 Basel, CH
Name:
KAUL, MartinAddress:
4002 Basel, CH
Name:
KINHIKAR, ArvindAddress:
Cambridge, Massachusetts 02139, US
Name:
RADIVOJEVIC, AndrijanaAddress:
East Hanover, New Jersey 07936, US
Name:
SEVERIN, ThomasAddress:
4002 Basel, CH
Name:
STORIM, JulianAddress:
4002 Basel, CH
Name:
VITALITI GARAMI, AlessandraAddress:
4002 Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201962851996 PDate:
23.5.2019Country:
US
Classification
Categories:
A61K 31/505, A61P 17/00, A61P 37/08